021-51111890
购物车（）
sales@molnova.cn
Seganserin
CAS No. 87729-89-3
Seganserin ( —— )
产品货号. M36225 CAS No. 87729-89-3
Seganserin, a non-selective 5-hydroxytryptamine 2-HT receptor antagonist, reversed the inhibitory effects of fluoxetine and quipazine on luteinizing hormone-induced hyperphagia, depression and nociception, and reversed the antidepressant and analgesic effects induced by fluoxetine and quipazine.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2755 | 有现货 |
|
| 10MG | ￥4076 | 有现货 |
|
| 25MG | ￥6371 | 有现货 |
|
| 50MG | ￥8621 | 有现货 |
|
| 100MG | ￥11250 | 有现货 |
|
| 500MG | ￥22320 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Seganserin
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Seganserin, a non-selective 5-hydroxytryptamine 2-HT receptor antagonist, reversed the inhibitory effects of fluoxetine and quipazine on luteinizing hormone-induced hyperphagia, depression and nociception, and reversed the antidepressant and analgesic effects induced by fluoxetine and quipazine.
-
产品描述Seganserin, a non-selective 5-hydroxytryptamine 2-HT receptor antagonist, reversed the inhibitory effects of fluoxetine and quipazine on luteinizing hormone-induced hyperphagia, depression and nociception, and reversed the antidepressant and analgesic effects induced by fluoxetine and quipazine.
-
体外实验——
-
体内实验——
-
同义词——
-
通路GPCR/G Protein
-
靶点5-HT Receptor
-
受体5-HT Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number87729-89-3
-
分子量471.54
-
分子式C29H27F2N3O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(=C1CCN(CCC=2C(=O)N3C(=NC2C)C=CC=C3)CC1)(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Zalospirone
Zalospirone is a 5-HT1A receptor agonist that can be used to study anxiety disorders and major depressive disorder.
-
Lumateperone tosylat...
Lumateperone (ITI-007) 是一种有效的 5-HT2A 拮抗剂 (Ki=0.54 nM)、突触后 D2 拮抗剂 (Ki=32 nM) 和 SERT 阻滞剂 (Ki= 61 nM)。
-
Tiflucarbine
Tiflucarbine is a potential non-selective 5-HT agonist with antidepressant activity.Tiflucarbine dose-dependently increased the specific activity of soluble calmodulin (CaM)-dependent phosphodiesterase in rat brain.
